Today: 9 June 2026
GE Vernova stock slips into year-end as traders eye Fed minutes and Jan. 28 earnings
29 December 2025
2 mins read

GE Vernova stock slips into year-end as traders eye Fed minutes and Jan. 28 earnings

NEW YORK, December 28, 2025, 21:16 ET — Market closed.

  • GE Vernova shares last closed down 0.6% at $663.46 on Friday.
  • The company’s early-December investor update lifted 2026 targets and expanded shareholder returns, including a bigger buyback and dividend.
  • Markets reopen Monday with key U.S. data ahead, while GE Vernova’s next earnings report is expected in late January.

GE Vernova Inc. (GEV) shares ended the last session down 0.6% on Friday at $663.46. The stock traded between $660.49 and $668.20.

The move comes as investors head into the final trading days of the year still focused on power-demand plays tied to data centers and grid spending. GE Vernova has been a key beneficiary of that theme, with management pointing to a long-cycle buildout in electricity infrastructure.

Why it matters now: the company sits in a market where supply is tight for large gas turbines, and lead times are stretched. Reuters Breakingviews said customers have been warned they may wait years for deliveries as order books fill.

At an investor update in New York on Dec. 9, GE Vernova raised its multi-year outlook and laid out new 2026 targets. The company also said its board doubled the quarterly dividend to $0.50 per share and increased its share repurchase authorization to $10 billion, from $6 billion.

GE Vernova said it reaffirmed 2025 revenue guidance of $36 billion to $37 billion and an adjusted EBITDA margin of 8% to 9%. Adjusted EBITDA is a measure of operating profit before interest, taxes, depreciation and amortization, with certain items excluded.

The company also raised its 2025 free cash flow guidance to $3.5 billion to $4.0 billion and forecast $4.5 billion to $5.0 billion for 2026. Free cash flow is cash left after operating costs and capital spending.

Management highlighted order momentum in gas power. GE Vernova said it had signed 18 gigawatts of gas turbine contracts quarter-to-date and expected to reach 80 gigawatts of combined slot reservation agreements and backlog by year-end. (A gigawatt is a unit of power capacity.)

Capacity constraints are also shaping the competitive landscape. Reuters Breakingviews cited an Institute for Energy Economics and Financial Analysis report saying GE Vernova, Siemens Energy and Mitsubishi Heavy Industries account for about 90% of the market, with some customers facing waits of up to eight years.

Investors are also watching supply-chain risks tied to critical materials. CEO Scott Strazik said earlier this month the company was working with the U.S. government to bolster stockpiles of the rare earth element yttrium after Chinese export restrictions tightened supplies, Reuters reported.

Recent deal announcements have kept attention on demand across renewables and grids. GE Vernova agreed to supply turbines for a 256-megawatt wind farm in South Australia, Renewables Now reported, while its grid business in India has pointed to new high-voltage direct current work — HVDC, a technology used to move electricity efficiently over long distances.

Analysts have largely framed the stock’s December surge around the investor update’s higher targets and capital returns. William Blair analyst Jed Dorsheimer said the event “fired on all cylinders,” according to Reuters. Reuters

With the market closed, traders will be watching near-term technical markers from the last session, including support around Friday’s low near $660 and resistance around the session high near $668.

Before Monday’s open, attention turns to the week’s sparse U.S. calendar, including pending home sales due at 10 a.m. ET and minutes from the Federal Reserve’s December meeting due Tuesday. U.S. markets are closed on Thursday for New Year’s Day.

GE Vernova’s next major company catalyst is its fourth-quarter report, expected on or around Jan. 28, according to Nasdaq. Investors are likely to focus on updates to the 2026 margin path and whether free-cash-flow performance tracks the company’s 2025 range.

GE Vernova was spun off from General Electric in 2024 and operates across power, wind and electrification equipment and services.

Stock Market Today

  • Cotton Futures Hold Steady Amid Mixed Trading and Market Moves
    June 9, 2026, 9:23 AM EDT. Cotton futures showed mixed performance on Monday with 5 to 15 point gains in most contracts, except July which fell 25 points by midday. The US dollar index declined to 99.94, while crude oil prices rose by 79 cents. Weekly Commodity Futures Trading Commission (CFTC) data revealed speculative funds reduced their net long positions in cotton by 1,798 contracts to 52,402 as of June 2. The Seam reported sales of 1,311 bales at 74.00 cents per pound, while the Cotlook A Index dropped 135 points to 86.15 cents on Friday. ICE certified cotton stocks increased by 11,219 bales to 261,648 on June 5. Key futures: July cotton at 73.5 cents (down 25), December 77.59 (up 11), March 78.85 (up 5). This reflects cautious market sentiment amid variable data.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Procter & Gamble Stock: PG Forecasts, Dividend Outlook, and What to Watch as Markets Reopen
Previous Story

Procter & Gamble Stock: PG Forecasts, Dividend Outlook, and What to Watch as Markets Reopen

Altria stock drops on ex-dividend move as Juul patent fight returns to view
Next Story

Altria stock drops on ex-dividend move as Juul patent fight returns to view

Go toTop